Home/Alvotech/Joseph E. McClellan
JE

Joseph E. McClellan

Chief Operating Officer

Alvotech

Alvotech Pipeline

DrugIndicationPhase
AVT02Immunology (e.g., Rheumatoid Arthritis, Psoriasis)Approved
AVT04Immunology (e.g., Psoriasis, Crohn's Disease)Approved
AVT03Bone Disease (Osteoporosis, SREs)Approved
AVT05Immunology (e.g., Rheumatoid Arthritis, Psoriatic Arthritis)Approved
AVT06Ophthalmology (nAMD, DME, RVO)Approved
AVT23Respiratory (Asthma, Chronic Spontaneous Urticaria)Clinical Trials
AVT16Immunology (Ulcerative Colitis, Crohn's Disease)Clinical Trials
AVT33Oncology (Various Cancers)Early Phase